Patent · US Active

Therapeutic heterocyclic compounds

US11040033B2 · kind B2 · utility

1Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 2018
Grant dateJun 22, 2021
Priority date—
Expiry dateAug 20, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having the following Formula I and/or Formula II and methods of their use and preparation are disclosed:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.